FDA advisers recommend approval of Sanofi-Aventis vaccine

02/27/2007 | TheStreet.com · Wall Street Journal, The

An FDA advisory panel recommended approval of the Sanofi-Aventis bird flu vaccine, despite limited evidence of its effectiveness. Currently there are no bird flu vaccines approved for use in the U.S., and the government wants to stockpile the Sanofi-Aventis vaccine for use in a pandemic.

View Full Article in:

TheStreet.com · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC